ArticleOncology letters2025

Efficacy of cadonilimab and anlotinib combination in treating multiple drug‑resistant pulmonary large cell neuroendocrine carcinoma: A case report and literature review.

Xi Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.